Pricing Log in Create free account

Cyteir Therapeutics, Inc. (CYTT) vs LENZ Therapeutics, Inc. (LENZ)

Cyteir Therapeutics, Inc. and LENZ Therapeutics, Inc. are both Biotechnology companies. Cyteir Therapeutics, Inc. and LENZ Therapeutics, Inc. are of similar size ($112.2M and $108.7M). Cyteir Therapeutics, Inc. has the higher net margin (0.00% vs −586.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Cyteir Therapeutics, Inc. leads on 11 and LENZ Therapeutics, Inc. on 2.

Valuation

Metric CYTT LENZ Biotechnology median
P/E n/m n/m 8.50
P/S n/m 4.78 9.71
P/B 0.87 0.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.55 0.85 0.64
EV/Sales n/m (5.36) 9.21
Earnings yield (31.23%) (125.08%) (33.15%)
Free cash flow yield (23.50%) (111.53%) (25.50%)

Profitability

Metric CYTT LENZ Biotechnology median
Gross margin 0.00% 93.69% 65.16%
Operating margin 0.00% (631.70%) 0.00%
Net margin 0.00% (586.74%) 0.00%
Free cash flow margin 0.00% (532.80%) 0.00%
Return on equity (23.80%) (59.21%) (56.36%)
Return on assets (22.70%) (55.52%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYTT LENZ Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 39.35% (21.79%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CYTT LENZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 21.89 13.55 4.72
Net debt to EBITDA 3.10 3.22 0.96

Dividend

Metric CYTT LENZ Biotechnology median
Dividend yield — 0.00% 0.09%
Payout ratio — — —

Size

Metric CYTT LENZ Biotechnology median
Market cap 108.72m 112.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack